Physician profile
Christopher M Lam
NPI 1114144839
$753.20
in general payments reported to CMS, 2019-2025
7 companies · $26.66 in 2025
The $26.66 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $337 · 2022: $35.74 · 2023: $275 · 2024: $78.97 · 2025: $26.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $349.91 | 2021-2025 | Mounjaro, Zepbound, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.21 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $80.01 | 2021-2023 | Farxiga |
| Novo Nordisk INC | $57.73 | 2021-2023 | Wegovy, Saxenda |
| Organon LLC | $54.97 | 2021-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $36.98 | 2021-2023 | M-M-R II, Gardasil 9, Vaxneuvance |
| Medtronic, INC. | $22.39 | 2024 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.